Follow us...

 

Search News Archives

 

Special Offers and Promotions

 

 

News Channels

 

Laboratory Products

 

 

View Channel

News

 

 

View Channel

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

Pre-Clinical Vaccine Adjuvant and Therapeutics Manufacturing

publication date: May 25, 2021
 | 
author/source: Analytik Ltd

preclinical-vaccine-adjuvant-and-therapeutics

 

Analytik reports how its Microfluidizer® processors are enabling researchers develop a range of therapeutic formulations including vaccine adjuvants, liposomes and lipid nanoparticles.

By reducing particle size uniformly, Microfluidizers from Analytik are helping a growing number of pharmaceutical companies and Contact Development and Manufacturing Organisations (CDMOs) improve the efficacy, bioavailability, stability and process efficiency of their drugs. Today, Microfluidizer® technology from Analytik is widely viewed as the gold standard for scalable uniform particle size reduction for vaccine adjuvants, dispersions, liposomes and cell disruption manufacturing processes.

James Anderson, product specialist at Analytik commented "Currently we are seeing increased interest in using our Microfluidizer systems particularly for vaccine and therapeutics development targeting treatment of or vaccination against the SARS-CoV-2 Coronavirus and its associated COVID-19 condition. All vaccines and injectable therapeutics need to be sterile - this is achieved by aseptic processing in a sterile environment often followed by sterile filtration of the adjuvant nanoemulsion.  Both approaches incur challenges and costs but is vital for the safety and quality of the product. Creating a nanoemulsion with a precise distribution curve and droplet size is challenging but will affect the ease with which the emulsion can be sterile filtered. Beneficially, our high shear processing technology produces precisely controlled particle sizes with a narrow size distribution range which creates nanoemulsions that can be successfully sterile filtered even at high volume throughputs with minimal yield losses. As a result, formulations can be produced at production scale, directly scaled from the lab range of Microfluidizer equipment".

Analytik offers a complete range of Microfluidizer® technology that enables you to seamlessly scale up from batch to lab, pilot and even production volumes.

 

About Analytik

For over 15 years - Analytik has been a trusted supplier of cutting-edge scientific instrumentation to leading organisations throughout the UK and Ireland. Specialists in providing and supporting pioneering technology, we deliver added value through specialised consultative expertise and comprehensive pre- and post-sales support  to ensure that our customers get the most out of their investment.

 

Company Profile | Recent news

 

 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners